Detection of prostate cancer in the PSA gray zone using prostate-specific antigen mass ratio combined with PI-RADS score
Background: The study aimed to assess the diagnostic performance of prostate-specific antigen mass ratio (PSAMR) in combination with the Prostate Imaging Reporting and Data System (PI-RADS) score for detecting prostate cancer (PCa) in patients presenting with mildly elevated prostate-specific ant...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MRE Press
2025-07-01
|
| Series: | Journal of Men's Health |
| Subjects: | |
| Online Access: | https://oss.jomh.org/files/article/20250730-588/pdf/JOMH2025032102.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839606202723467264 |
|---|---|
| author | Weilin Li Zhiqi Wang Weihong Zhao Gaobo Zhou Miaomiao Peng Zhicheng Su Tao-Hsin Tung |
| author_facet | Weilin Li Zhiqi Wang Weihong Zhao Gaobo Zhou Miaomiao Peng Zhicheng Su Tao-Hsin Tung |
| author_sort | Weilin Li |
| collection | DOAJ |
| description | Background: The study aimed to assess the diagnostic performance of
prostate-specific antigen mass ratio (PSAMR) in combination with the Prostate
Imaging Reporting and Data System (PI-RADS) score for detecting prostate cancer
(PCa) in patients presenting with mildly elevated prostate-specific antigen (PSA)
levels (4–10 ng/mL). Methods: A retrospective analysis
was conducted involving 208 patients with PSA levels between 4 and 10 ng/mL who
underwent multiparametric magnetic resonance imaging (mpMRI) and transrectal
ultrasound-guided transperineal prostate biopsy. PSA-derived parameters and
PI-RADS scores were incorporated into logistic regression models to predict the
presence of PCa. Diagnostic accuracy was assessed using receiver operating
characteristic (ROC) curve analysis. Additionally, Spearman’s correlation
analysis was performed to determine the relationship between each parameter and
the prediction model with disease severity ratings. Results: Of the 208
patients, PCa was confirmed by biopsy in 62 cases. The combination of PSAMR and
PI-RADS score yielded an area under the ROC curve (AUC) of 0.874 (95% confidence
interval (CI): 0.821–0.916, p < 0.001), which was higher than the
AUCs for PSAMR or PI-RADS score alone, indicating superior diagnostic accuracy.
Correlation analysis also revealed that the combined model had the strongest
association with disease severity. The order of correlation coefficients was as
follows: PSAMR combined with PI-RADS score (Model A) > Prostate-specific
antigen density (PSAD) combined with PI-RADS score (Model B) > PI-RADS score
alone > PSAMR alone > PSAD alone. Conclusions: The combination of
PSAMR and PI-RADS score significantly enhances the accuracy of PCa detection in
patients with PSA levels of 4–10 ng/mL. This approach may contribute to more
effective screening strategies while minimizing unnecessary biopsies.
Furthermore, given their positive correlation with disease severity, PSAMR and
PI-RADS scores together may also assist in predicting PCa progression risk. |
| format | Article |
| id | doaj-art-6bcace94b09f4a3781aa1ad9ebd97c24 |
| institution | Matheson Library |
| issn | 1875-6867 1875-6859 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | MRE Press |
| record_format | Article |
| series | Journal of Men's Health |
| spelling | doaj-art-6bcace94b09f4a3781aa1ad9ebd97c242025-08-01T08:30:07ZengMRE PressJournal of Men's Health1875-68671875-68592025-07-01217566310.22514/jomh.2025.096S1875-6867(25)00413-0Detection of prostate cancer in the PSA gray zone using prostate-specific antigen mass ratio combined with PI-RADS scoreWeilin Li0Zhiqi Wang1Weihong Zhao2Gaobo Zhou3Miaomiao Peng4Zhicheng Su5Tao-Hsin Tung6Department of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, 317000 Linhai, Zhejiang, ChinaDepartment of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310016 Hangzhou, Zhejiang, ChinaDepartment of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, 317000 Linhai, Zhejiang, ChinaDepartment of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, 317000 Linhai, Zhejiang, ChinaDepartment of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, 317000 Linhai, Zhejiang, ChinaDepartment of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, 317000 Linhai, Zhejiang, ChinaEvidence-Based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, 317000 Linhai, Zhejiang, ChinaBackground: The study aimed to assess the diagnostic performance of prostate-specific antigen mass ratio (PSAMR) in combination with the Prostate Imaging Reporting and Data System (PI-RADS) score for detecting prostate cancer (PCa) in patients presenting with mildly elevated prostate-specific antigen (PSA) levels (4–10 ng/mL). Methods: A retrospective analysis was conducted involving 208 patients with PSA levels between 4 and 10 ng/mL who underwent multiparametric magnetic resonance imaging (mpMRI) and transrectal ultrasound-guided transperineal prostate biopsy. PSA-derived parameters and PI-RADS scores were incorporated into logistic regression models to predict the presence of PCa. Diagnostic accuracy was assessed using receiver operating characteristic (ROC) curve analysis. Additionally, Spearman’s correlation analysis was performed to determine the relationship between each parameter and the prediction model with disease severity ratings. Results: Of the 208 patients, PCa was confirmed by biopsy in 62 cases. The combination of PSAMR and PI-RADS score yielded an area under the ROC curve (AUC) of 0.874 (95% confidence interval (CI): 0.821–0.916, p < 0.001), which was higher than the AUCs for PSAMR or PI-RADS score alone, indicating superior diagnostic accuracy. Correlation analysis also revealed that the combined model had the strongest association with disease severity. The order of correlation coefficients was as follows: PSAMR combined with PI-RADS score (Model A) > Prostate-specific antigen density (PSAD) combined with PI-RADS score (Model B) > PI-RADS score alone > PSAMR alone > PSAD alone. Conclusions: The combination of PSAMR and PI-RADS score significantly enhances the accuracy of PCa detection in patients with PSA levels of 4–10 ng/mL. This approach may contribute to more effective screening strategies while minimizing unnecessary biopsies. Furthermore, given their positive correlation with disease severity, PSAMR and PI-RADS scores together may also assist in predicting PCa progression risk.https://oss.jomh.org/files/article/20250730-588/pdf/JOMH2025032102.pdfprostate cancerprostate specific antigenmagnetic resonance imagingpi-radspsamr |
| spellingShingle | Weilin Li Zhiqi Wang Weihong Zhao Gaobo Zhou Miaomiao Peng Zhicheng Su Tao-Hsin Tung Detection of prostate cancer in the PSA gray zone using prostate-specific antigen mass ratio combined with PI-RADS score Journal of Men's Health prostate cancer prostate specific antigen magnetic resonance imaging pi-rads psamr |
| title | Detection of prostate cancer in the PSA gray zone using
prostate-specific antigen mass ratio combined with PI-RADS score |
| title_full | Detection of prostate cancer in the PSA gray zone using
prostate-specific antigen mass ratio combined with PI-RADS score |
| title_fullStr | Detection of prostate cancer in the PSA gray zone using
prostate-specific antigen mass ratio combined with PI-RADS score |
| title_full_unstemmed | Detection of prostate cancer in the PSA gray zone using
prostate-specific antigen mass ratio combined with PI-RADS score |
| title_short | Detection of prostate cancer in the PSA gray zone using
prostate-specific antigen mass ratio combined with PI-RADS score |
| title_sort | detection of prostate cancer in the psa gray zone using prostate specific antigen mass ratio combined with pi rads score |
| topic | prostate cancer prostate specific antigen magnetic resonance imaging pi-rads psamr |
| url | https://oss.jomh.org/files/article/20250730-588/pdf/JOMH2025032102.pdf |
| work_keys_str_mv | AT weilinli detectionofprostatecancerinthepsagrayzoneusingprostatespecificantigenmassratiocombinedwithpiradsscore AT zhiqiwang detectionofprostatecancerinthepsagrayzoneusingprostatespecificantigenmassratiocombinedwithpiradsscore AT weihongzhao detectionofprostatecancerinthepsagrayzoneusingprostatespecificantigenmassratiocombinedwithpiradsscore AT gaobozhou detectionofprostatecancerinthepsagrayzoneusingprostatespecificantigenmassratiocombinedwithpiradsscore AT miaomiaopeng detectionofprostatecancerinthepsagrayzoneusingprostatespecificantigenmassratiocombinedwithpiradsscore AT zhichengsu detectionofprostatecancerinthepsagrayzoneusingprostatespecificantigenmassratiocombinedwithpiradsscore AT taohsintung detectionofprostatecancerinthepsagrayzoneusingprostatespecificantigenmassratiocombinedwithpiradsscore |